Promising galactose-decorated biodegradable poloxamer 188-PLGA diblock copolymer nanoparticles of resibufogenin for enhancing liver cancer therapy

References

• Avgoustakis K, Beletsi A, Panagi Z. (2003). Effect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA-mPEG nanoparticles. Int J Pharm 259:115–27.
   PubMed Web of Science ®Google Scholar
• Batrakova EV, Miller DW, Li S, et al. (2001). Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies. J Pharmacol Exp Ther 296:551–7.
   PubMed Web of Science ®Google Scholar
• Bick RJ, Poindexter BJ, Sweney RR, Dasgupta A. (2002). Effects of Chan Su, a traditional Chinese medicine, on the calcium transients of isolated cardiomyocytes: cardiotoxicity due to more than Na, K-ATPase blocking. Life Sci 72:699–709.
   PubMed Web of Science ®Google Scholar
• Cheng MR, Li Q, Wan T, et al. (2012). Galactosylated chitosan/5-fluorouracil nanoparticles inhibit mouse hepatic cancer growth and its side effects. World J Gastroenterol 18:6076–87.
   PubMed Web of Science ®Google Scholar
• Choi SH, Park JY, Kang W, et al. (2015). Knockdown of HIF-1α and IL-8 induced apoptosis of hepatocellular carcinoma triggers apoptosis of vascular endothelial cells. Apoptosis 21:85–95.
   Web of Science ®Google Scholar
• Chu Q, Xu H, Gao M, et al. (2016). Liver-targeting Resibufogenin-loaded poly(lactic-co-glycolic acid)-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for liver cancer therapy. Int J Nanomedicine 11:449–63.
   PubMed Web of Science ®Google Scholar
• Cong WM, Wu MC. (2015). New insights into molecular diagnostic pathology of primary liver cancer: Advances and challenges. Cancer Lett 368:14–19.
   PubMed Web of Science ®Google Scholar
• Craparo EF, Licciardi M, Conigliaro A, et al. (2015). Hepatocyte-targeted fluorescent nanoparticles based on a polyaspartamide for potential theranostic applications. Polymer 70:257–70.
   Web of Science ®Google Scholar
• Demirci S, Doğan A, Başak N, et al. (2015). A Schiff base derivative for effective treatment of diethylnitrosamine-induced liver cancer in vivo. Anticancer Drugs 26:555–64.
   PubMed Web of Science ®Google Scholar
• Edmondson HA, Steiner PE. (1954). Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 7:462–503.
   PubMed Web of Science ®Google Scholar
• Fox ME, Szoka FC, Frechet JMJ. (2009). Soluble polymer carriers for the treatment of cancer: the importance of molecular architecture. Acc Chem Res 42:1141–51.
   PubMed Web of Science ®Google Scholar
• Huang Y, Xiao J, Meng S, et al. (2006). The study of resibufogenin on induction of the apoptosis of human hepatocarcinoma Bel-7402 cells by the mitochondrial-dependent pathway. Chin J Clin Tumour 33:1141–5.
   Google Scholar
• Huber HJ, Laussmann MA, Prehn JH, Rehm M. (2010). Diffusion is capable of translating anisotropic apoptosis initiation into a homogeneous execution of cell death. BMC Syst Biol 4:9.
   PubMed Web of Science ®Google Scholar
• Ishibashi S, Hammer RE, Herz J. (1994). Asialoglycoprotein receptor deficiency in mice lacking the minor receptor subunit. J Biol Chem 269:27803–6.
   PubMed Web of Science ®Google Scholar
• Kabanov AV, Batrakova EV, Alakhov VY. (2002). Pluronic block copolymers for overcoming drug resistance in cancer. Adv Drug Deliv Rev 54:759–79.
   PubMed Web of Science ®Google Scholar
• Liao YH, Lin CC, Lai HC, et al. (2015). Adjunctive traditional Chinese medicine therapy improves survival of liver cancer patients. Liver Int 35:2595–602.
   PubMed Web of Science ®Google Scholar
• Liu L, Yang T, Simon SA. (2004). The protein tyrosine kinase inhibitor, genistein, decreases excitability of nociceptive neurons. Pain 112:131–41.
   PubMed Web of Science ®Google Scholar
• Liu P, Sun Y, Wang Q, et al. (2014). Intracellular trafficking and cellular uptake mechanism of mPEG–PLGA–PLL and mPEG–PLGA–PLL–Gal nanoparticles for targeted delivery to hepatomas. Biomaterials 35:760–70.
   PubMed Web of Science ®Google Scholar
• Mei L, Zeng X. Preparation and application of star-shaped CA-PLGA-TPGS polymer. China ZL201210292220.7. 2012-12-05.
   Google Scholar
• Meng S, Dong X, Xiao J, et al. (2006). Interventional effect of resibufogenin on the cell growth of human gastric cancer BGC-823 cell line. Chin J Clin Rehabil 10:138–41.
   Google Scholar
• Mundargi RC, Babu VR, Rangaswamy V, et al. (2008). Nano/micro technologies for delivering macromolecular therapeutics using poly (D,L-lactide-co-glycolide) and its derivatives. J Control Release 125:193–209.
   PubMed Web of Science ®Google Scholar
• Ngamwongsatit P, Banada PP, Panbangred W, Bhunia AK. (2008). WST-1-based cell cytotoxicity assay as a substitute for MTT-based assay for rapid detection of toxigenic Bacillus species using CHO cell line. J Microbiol Methods 73:211–15.
   PubMed Web of Science ®Google Scholar
• Panyama J, Sahoo SK, Prabha S, et a1. (2003). Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(d,l-lactide-co-glycolide) nanoparticles. Int J Pharm 262:1–11.
   PubMed Web of Science ®Google Scholar
• Peça IN, Petrova KT, Cardoso MM, Barros MT. (2012). Preparation and characterization of polymeric nanoparticles composed of poly(dl-lactide-co-glycolide) and poly(dl-lactide-co-glycolide)-co-poly(ethylene glycol)-10%-triblock end-capped with a galactose moiety. React Funct Polym 72:729–7.
   Web of Science ®Google Scholar
• Qi F, Li A, Inagaki Y, et al. (2011). Antitumor activity of extracts and compounds from the skin of the toad Bufo bufo gargarizans Cantor. Int Immunopharmacol 11:342–9.
   PubMed Web of Science ®Google Scholar
• Qiu DZ, Zhang ZJ, Wu WZ, Yang YK. (2013). Bufalin, a component in Chansu, inhibits proliferation and invasion of hepatocellular carcinoma cells. BMC Complement Altern Med 13:185.
   PubMed Web of Science ®Google Scholar
• Rigopoulou EI, Roggenbuck D, Smyk DS, et al. (2012). Asialoglycoprotein receptor (ASGPR) as target autoantigen in liver autoimmunity: lost and found. Autoimmun Rev 12:260–9.
   PubMed Web of Science ®Google Scholar
• Roggenbuck D, Mytilinaiou MG, Lapin SV, et al. (2012). Asialoglycoprotein receptor (ASGPR): a peculiar target of liver-specific autoimmunity. Auto Immun Highlights 3:119–25.
   PubMedGoogle Scholar
• Rude MK, Crippin JS. (2015). Liver transplantation for hepatocellular carcinoma. Curr Gastroenterol Rep 17:1–11.
   Google Scholar
• Sengupta D, Chowdhury KD, Sarkar A, et al. (2014). Berberine and S allyl cysteine mediated amelioration of DEN + CCl4 induced hepatocarcinoma. Biochim Biophys Acta 1840:219–44.
   PubMed Web of Science ®Google Scholar
• Wang C, Li Y, Chen N, et al. (2006). Inhibitory effect of resibufogenin on transphantation tumor growth of human cervical cancer Hela cells in rude mice. J Beijing Univ Tradit Chin Med 29:184–7.
   Google Scholar
• Wang Y, Jiang G, Qiu T, Ding F. (2012). Preparation and evaluation of paclitaxel-loaded nanoparticle incorporated with galactose-carrying polymer for hepatocyte targeted delivery. Drug Dev Ind Pharm 38:1039–46.
   PubMed Web of Science ®Google Scholar
• Wang ZJ, Sun L, Heinbockel T. (2014). Resibufogenin and cinobufagin activate central neurons through an ouabain-like action. PLoS One 9:e113272.
   PubMed Web of Science ®Google Scholar
• Watcharin W, Schmithals C, Pleli T, et al. (2015). Detection of hepatocellular carcinoma in transgenic mice by Gd-DTPA- and rhodamine 123-conjugated human serum albumin nanoparticles in T1 magnetic resonance imaging. J Control Release 199:63–71.
   PubMed Web of Science ®Google Scholar
• Xiao Y, Zhang J, Wu B. (2006). The investigation of the effect on human hepatoma cell apoptosis induced by resibufogenin. China Biotechnol 26:36–9.
   Google Scholar
• Xie JT, Dey L, Wu JA, et al. (2001). Cardiac toxicity of resibufogenin: electrophysiological evidence. Acta Pharmacol Sin 22:289–97.
   PubMed Web of Science ®Google Scholar
• Yan F, Zhang C, Zheng Y, et al. (2010). The effect of poloxamer 188 on nanoparticle morphology, size, cancer cell uptake, and cytotoxicity. Nanomedicine 6:170–8.
   PubMed Web of Science ®Google Scholar
• Yan JJ, Liao JZ, Lin JS, He XX. (2015). Active radar guides missile to its target: receptor-based targeted treatment of hepatocellular carcinoma by nanoparticulate systems. Tumor Biol 36:55–67.
   PubMed Web of Science ®Google Scholar
• Zhang DM, Liu JS, Deng LJ, et al. (2013). Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway. Carcinogenesis 34:1331–42.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Ren JS, Shi JF, et al. (2015). International trends in primary liver cancer incidence from 1973 to 2007. BMC Cancer 15:94.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Tang L, Sun L, et al. (2010). A novel paclitaxel-loaded poly(epsilon-caprolactone)/Poloxamer 188 blend nanoparticle overcoming multidrug resistance for cancer treatment. Acta Biomater 6:2045–52.
   PubMed Web of Science ®Google Scholar
• Zhu Q, Zhang M, Shi M, et al. (2016). Human B cells have an active phagocytic capability and undergo immune activation upon phagocytosis of Mycobacterium tuberculosis. Immunobiology 221:558–67.
   PubMed Web of Science ®Google Scholar
• Zhu XL, Du YZ, Yu RS, et al. (2013). Galactosylated chitosan oligosaccharide nanoparticles for hepatocellular carcinoma cell-targeted delivery of adenosine triphosphate. Int J Mol Sci 14:15755–66.
   PubMed Web of Science ®Google Scholar